OLMA

Olema Pharmaceuticals, Inc. OLMA

OLMA
Olema Pharmaceuticals, Inc. PMVP
PMV Pharmaceuticals, Inc. CGEM
Cullinan Therapeutics, Inc. ELVN
Enliven Therapeutics, Inc. IMRX
Immuneering Corporation PRAX
Praxis Precision Medicines, Inc. ALGS
Aligos Therapeutics, Inc. ORIC
ORIC Pharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode OLMA PMVP CGEM ELVN IMRX PRAX ALGS ORIC
6M 180.37 % 54.82 % -4.02 % 26.11 % 375.19 % 79.09 % 131.13 % 178.05 %
YTD 89.77 % -11.76 % -40.27 % -12.89 % 177.38 % -33.02 % -76.32 % 65.62 %
1Y -9.89 % -10.00 % -54.41 % -24.97 % 206.50 % -23.96 % 30.43 % 43.40 %
3Y 257.09 % -88.92 % -42.55 % 101.74 % -52.85 % 78.43 % -66.32 % 335.67 %
5Y -78.43 % -96.24 % -75.26 % -73.77 % -65.15 % -87.23 % -97.46 % -40.16 %
10Y -78.43 % -96.40 % -75.26 % -65.30 % -65.15 % -87.23 % -97.46 % -46.92 %
From the beginning -78.43 % -96.40 % -75.26 % -65.30 % -65.15 % -87.23 % -97.46 % -46.92 %

Dividend